Carcinoma
1,25-Dihydroxyvitamin D3 increases the cellular content of the calcium-activated neutral protease mu-calpain in renal cell carcinoma.
causal interaction
ongoing research
unassigned
1
4
0
Carcinoma, Renal Cell
1,25-Dihydroxyvitamin D3 increases the cellular content of the calcium-activated neutral protease mu-calpain in renal cell carcinoma.
causal interaction
ongoing research
unassigned
1
4
0
Brain Ischemia
20(R)-Ginsenoside Rg3 protects SH-SY5Y cells against apoptosis induced by oxygen and glucose deprivation/reperfusion.
ongoing research
unassigned
2
0
Tauopathies
?-Lipoic acid improves abnormal behavior by mitigation of oxidative stress, inflammation, ferroptosis, and tauopathy in P301S Tau transgenic mice.
causal interaction
unassigned
3
0
Multiple Endocrine Neoplasia
A 500-kb sequence-ready cosmid contig and transcript map of the MEN1 region on 11q13.
ongoing research
unassigned
2
0
Multiple Endocrine Neoplasia Type 1
A 500-kb sequence-ready cosmid contig and transcript map of the MEN1 region on 11q13.
ongoing research
unassigned
2
0
Neoplasms
A 500-kb sequence-ready cosmid contig and transcript map of the MEN1 region on 11q13.
ongoing research
unassigned
2
0
Leukemia, Myeloid, Acute
A calcium- and calpain-dependent pathway determines the response to lenalidomide in myelodysplastic syndromes.
causal interaction
unassigned
1
0
Brain Injuries, Traumatic
A calpain inhibitor attenuates cortical cytoskeletal protein loss after experimental traumatic brain injury in the rat.
causal interaction
ongoing research
therapeutic application
unassigned
1
2
4
0
Carcinoma
A comparison of the intracellular distribution of mu-calpain, m-calpain, and calpastatin in proliferating human A431 cells.
unassigned
0
